Literature DB >> 25243680

Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial.

Dvora Frankenthal1, Yaffa Lerman, Edward Kalendaryev, Yehuda Lerman.   

Abstract

OBJECTIVES: To assess the effect of a Screening Tool of Older Persons potentially inappropriate Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) medication intervention on clinical and economic outcomes.
DESIGN: Parallel-group randomized trial.
SETTING: Chronic care geriatric facility. PARTICIPANTS: Residents aged 65 and older prescribed with at least one medication (N = 359) were randomized to receive usual pharmaceutical care or undergo medication intervention. INTERVENTION: Screening medications with STOPP/START criteria followed up with recommendations to the chief physician. MEASUREMENTS: The outcome measures assessed at the initiation of the intervention and 1 year later were number of hospitalizations and falls, Functional Independence Measure (FIM), quality of life (measured using the Medical Outcomes Study 12-item Short-Form Health Survey), and costs of medications.
RESULTS: The average number of drugs prescribed was significantly lower in the intervention than in the control group after 1 year (P < .001). The average drug costs in the intervention group decreased by 103 shekels (US$29) per participant per month (P < .001). The average number of falls in the intervention group dropped significantly (P = .006). Rates of hospitalization, FIM scores, and quality of life measurements were similar for both groups.
CONCLUSION: Implementation of STOPP/START criteria reduced the number of medications, falls, and costs in a geriatric facility. Their incorporation in those and similar settings is recommended.
© 2014, Copyright the Authors Journal compilation © 2014, The American Geriatrics Society.

Entities:  

Keywords:  START criteria; STOPP criteria; elderly adults; intervention

Mesh:

Year:  2014        PMID: 25243680     DOI: 10.1111/jgs.12993

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  62 in total

Review 1.  Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.

Authors:  Tim Johansson; Muna E Abuzahra; Sophie Keller; Eva Mann; Barbara Faller; Christina Sommerauer; Jennifer Höck; Christin Löffler; Anna Köchling; Jochen Schuler; Maria Flamm; Andreas Sönnichsen
Journal:  Br J Clin Pharmacol       Date:  2016-05-07       Impact factor: 4.335

Review 2.  Pharmacist services in nursing homes: A systematic review and meta-analysis.

Authors:  Shaun Wen Huey Lee; Vivienne Sook Li Mak; Yee Woon Tang
Journal:  Br J Clin Pharmacol       Date:  2019-11-03       Impact factor: 4.335

3.  Longitudinal patterns of potentially inappropriate prescribing in early old-aged people.

Authors:  Christina Raae Hansen; Stephen Byrne; Shane Cullinan; Denis O'Mahony; Laura J Sahm; Patricia M Kearney
Journal:  Eur J Clin Pharmacol       Date:  2017-11-25       Impact factor: 2.953

4.  Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old.

Authors:  Maarten Wauters; Monique Elseviers; Bert Vaes; Jan Degryse; Olivia Dalleur; Robert Vander Stichele; Thierry Christiaens; Majda Azermai
Journal:  Br J Clin Pharmacol       Date:  2016-08-03       Impact factor: 4.335

5.  Quality of pharmacotherapy in old age: focus on lists of Potentially Inappropriate Medications (PIMs) : Consensus statements from the European Science Foundation exploratory workshop.

Authors:  Majda Azermai; Robert R Vander Stichele; Monique M Elseviers
Journal:  Eur J Clin Pharmacol       Date:  2016-04-11       Impact factor: 2.953

Review 6.  A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set.

Authors:  Jean-Baptiste Beuscart; Lisa G Pont; Stefanie Thevelin; Benoit Boland; Olivia Dalleur; Anne W S Rutjes; Johanna I Westbrook; Anne Spinewine
Journal:  Br J Clin Pharmacol       Date:  2017-01-18       Impact factor: 4.335

7.  Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: A systematic review.

Authors:  Shakti Shrestha; Arjun Poudel; Kathryn Steadman; Lisa Nissen
Journal:  Br J Clin Pharmacol       Date:  2019-12-12       Impact factor: 4.335

8.  Effectiveness of using STOPP/START criteria to identify potentially inappropriate medication in people aged ≥ 65 years with chronic kidney disease: a randomized clinical trial.

Authors:  Krystina Parker; Ingrid Bull-Engelstad; Jūratė Šaltytė Benth; Willy Aasebø; Nanna von der Lippe; Morten Reier-Nilsen; Ingrid Os; Knut Stavem
Journal:  Eur J Clin Pharmacol       Date:  2019-07-29       Impact factor: 2.953

Review 9.  The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis.

Authors:  Andreas D Meid; Anette Lampert; Alina Burnett; Hanna M Seidling; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2015-06-12       Impact factor: 4.335

Review 10.  [List-based concepts in pharmacotherapy of older and geriatric patients].

Authors:  Ulrich Thiem
Journal:  Z Gerontol Geriatr       Date:  2018-05-03       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.